We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Niox Group Plc | NIOX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.80 | -1.15% | 68.80 | 16:35:16 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 69.60 | 69.40 | 70.80 | 68.80 | 69.60 |
| Industry Sector |
|---|
| BEVERAGES |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 26/03/2024 | Final | GBP | 0.01 | 23/05/2024 | 24/05/2024 | 24/06/2024 |
| 07/06/2023 | Special | GBP | 0.025 | 17/08/2023 | 18/08/2023 | 15/09/2023 |
| Top Posts |
|---|
Posted at 31/5/2024 15:37 by earwacks Holding up well since Griffiths reduced another 5% nearly. I think he reduced the day before it went ex div. Pretty impressive you can sell that many without denting the share price too much.He still holds 18%, about the same as Harwood. They have made a few million. Worth holding for the potential takeover and possible extra special dividend. Last year it paid for my flight to Australia. Not sure where to go this winter! |
Posted at 22/5/2024 09:42 by earwacks Slightly strange that we are at house brokers target price again. Fairly quiet Agm announcement but inline with management expectations and a couple of million up on same time last year (not forgetting they paid out 10 million special dividend, so actually nearer 12 million up on last year!) but for the special dividend their cash position would be up over 30 per cent! Should get AGM result later today. Ex dividend tomorrow if motion carried. Maybe a little more about possible further special. Probably more news to come in July update regarding product developments. All resolutions passed ex div tomorrow, paid June 24th |
Posted at 22/5/2024 07:13 by badday Short and sweet, and bowling along nicely.Trading Update We are pleased to report that our business has continued to perform strongly in the year to date, in line with management expectations. In January 2024, NIOX settled returns claims amounting to £0.4m in relation to the discontinued business. The unaudited cash balance as at 30 April 2024 was £23.7m (31 December 2023: £19.9m), with no bank borrowings. NIOX expects to give a trading update in relation to the six months ended 30 June 2024 around the middle of July. |
Posted at 09/5/2024 04:08 by earwacks Year end they were back to nearly 20 million cash. End of feb they had 22.5 million. They have another 4.4 million dollars from Beyond air in August with up to 6 million dollars in royalties there after. They have 2 million spend on thr development of pro Niox this year. I think Mills thought they would finish the year with 30 million. Looks a bit conservative to me. I think they can do that after dividends the way they are going. That’s a shed load of money, over 10 percent of Market cap in cash generation per year! |
Posted at 08/5/2024 20:56 by thedudie The special divi was announced at start of June last year about 6 weeks before the July trading statement.Who knows they might have better things to do with the money this year - I am happy either way. |
Posted at 08/5/2024 16:55 by earwacks TU July 18th last year. I guess we won’t hear about another special dividend until then |
Posted at 02/5/2024 08:37 by earwacks Have been delving further back into Circassia history. This is looking one of the more bizar Aim stories and there have been many. Apparently cir floated at £3.60 back in the day. Something to do with cat allergies! Thats me. My partner has two. Nightmare, but we also have a dog to defend me. Anyway obviously cir was a complete crackpot company under old management and got badly tangled up with Astra. Guess who came out on top? However Ian Johnson, like Chris Mills I clocked when he took Bioquel on a very successful journey about the same time as Cir were in their early days. Quite how Johnson came to Cir to take the reigns I’m not sure, but he certainly worked his magic on it. Just watched an old video of Andy Brough (schroders)talking about how he always gets interested when he hears Chris Mills is involved on the board of a biotech. I remember Mills saying all the serious money had been made on Niox when it was 50p, and it couldnt make 60p under its own steam, inferring a buyout I guess. It went on up to 75p under its own steam with a little help from a special dividend payout. Subsequently it fell back a bit. People keep saying its expensive, but I feel that is only when looking at current valuations. I remember valuations in companies being a lot higher than this pre Covid. Recently Niox have offered employees a 3 year savings plan for shares at 51p which I find curious. In light of recent developments with COPD, the upgrading of a new FeNo diagnostic instrument (the old one having a 5 year max shelf life limit) and the development of a home diagnostic kit, I find myself thinking these shares are bloody cheap still. Incidentally Mills is on the board of EKF (I have a smaller portion) and has made two £100,000 this year, one very recently when they announced results which as expected were not great. But they make enzymes! Or are trying to. He also has connections with Vrci and Renx, (kidney diagnostics) both of which have come off the boil a bit. Tempted for a small position, but they would definitely stretch my risk appetite. And why not just stick with what you know, Niox! |
Posted at 30/4/2024 08:58 by earwacks Edward. Sounds fantastic. If successful that doubly underestimates the potential for Niox. Even Chris Mills seems to have not understood Niox. I think it was last year he commented Niox couldn’t reach 60p under its own steam! It smashed through that in a couple of months. He has been very bullish and it was him that flagged up the humongous tax credit. Personally I thought a target by one broker of £1.20 under its own steam was not pie in the sky considering 95 percent of their market is up for grabs. Requires replacing every 5 years depending on usage. Mills did point out this is a razor blade stock. Sounds like they have also reinvented another Gillette. dividend declared for next months and possibly another special on the cards. Have to admit this is now about a third of my portfolio and am not interested in top slicing. I have a few duffers in my portfolio but would rather kick them out frankly. My best pick since Arm holdings. Gl |
Posted at 27/4/2024 15:19 by earwacks Astra dissolved their partnership with Circassia over Tudorza and Duklar inhaler for COPD.Astra retained commercial rights in consideration of 150 million dollar debt and retained 18 percent of Circassia, now Niox. Astra have since offloaded this product. Not sure how successful it has been. Probably nothing like the FeNo tester. What Niox have is the development of the best Asthma diagnostic device and 600 million tax credit for the Circassia debacle. Meaning they will never pay tax on their very cash generative device. The tax credit is also transferable which makes it an added asset to their £270 million market cap. The directors are probably nearing retirement. They have built a highly profitable business from the wreckage of Circassia, making it a market leader in its field, but still only tapping 5 percent of possible world market. Added to that they are developing a domestic kit, which if successful will probably appeal to a us pharma giant, not necessarily just Astra, who as you say may not be interested as it is Gsk that have recently purchased a company that have developed an asthma drug. Potential for Niox is pretty big and are at an interesting stage where they might need some serious gearing up to reach potential global markets, whilst having converted themselves into a growing cash machine. Although expensive on last years results I don’t think forecasters have quite got their head around the potential of Niox yet |
Posted at 23/2/2024 18:18 by earwacks I think it’s held up well considering The uk is the worst performing market in the world and many British companies make most of their money in global business.This is a recent high for NIOX. It is similar to share price movement last year between update and actual results. News on dividend and cash position should help re establish the share price Then of course there is the expectant takeover by AZN Why else would they hold 16 percent of the. Company? Gl all |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
